Basics Equillium, Inc. IPO Date: October 8, 2018 Sector: Healthcare Industry: Biotech Market Cap: $113.65M Activated in VL: True Average Daily Range Avg Daily Range: $0.20 | 4.79% Avg Daily Range (30 D): $0.11 | 10.82% Avg Daily Range (90 D): $0.05 | 7.13% Institutional Daily Volume Avg Daily Volume: .48M Avg Daily Volume (30 D): 11.6M Avg Daily Volume (90 D): 4.33M Trade Size Avg Trade Size (Sh.): 241 Avg Trade Size (Sh.) (30 D): 416 Avg Trade Size (Sh.) (90 D): 412 Institutional Trades Total Inst.Trades: 31 Avg Inst. Trade: $1.23M Avg Inst. Trade (30 D): $.66M Avg Inst. Trade (90 D): $.66M Avg Inst. Trade Volume: .25M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.57M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 179.46K     News Sep 3, 2025 @ 11:30 AM These Were the 5 Top-Performing Stocks in the Nasd... Source: James Brumley Sep 22, 2024 @ 4:30 AM Graft versus Host Disease Market to Increase at a ... Source: Delveinsight Sep 16, 2024 @ 1:00 PM Vivtex Enters New Research Agreement w... Source: N/A May 9, 2024 @ 9:35 PM Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue... Source: Zacks Equity Research May 8, 2024 @ 10:25 PM Alector (ALEC) Reports Q1 Loss, Tops Revenue Estim... Source: Zacks Equity Research Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.57 $-.16 $-.24 Diluted EPS $-.57 $-.16 $-.24 Revenue $ 16.55M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -20.19M $ -5.74M $ -8.65M Operating Income / Loss $ -20.48M $ -6.23M $ -8.87M Cost of Revenue $ $ $ Net Cash Flow $ .5M $ -3.03M $ -3.58M PE Ratio